Vedolizumab-4014: A Phase 4, Open-Label Study to Evaluate Vedolizumab IV Dose Optimization on Treatment Outcomes in Nonresponders With Moderately to Severely Active Ulcerative Colitis

Project: Research project

Project Details

StatusActive
Effective start/end date6/19/186/19/21

Funding

  • Quintiles, Inc. (Agmt 06/19/18)
  • Takeda Development Center Americas, Inc. (Agmt 06/19/18)